For analysis purposes, the cohort was subsequently segregated according to different clinical and biological variables, such as sex, extrasellar growth of the tumor, radiological sinus invasion, the mutational status of GNAS, T2 hypointense signal80 and presurgical SRL treatment. This evidence concerns the gene GNAS and neoplasm.